We are a subsidiary of Cadila Pharmaceuticals, Ltd., India. Together we are committed to supplying affordable, quality formulations using some of the most innovative research methods and cutting-edge manufacturing processes. In addition to the collaboration with Cadila, Modavar has invested in its own state-of-the-art research and development facility in the U.S. to focus on novel liquid and semi-solid formulations. This facility is also a fully FDA-compliant manufacturing site from where we plan to launch new products in the U.S..
We have a strong pipeline of products at various stages of approval that leverage our patented formulations and development processes. In addition, our partner company, Cadila Pharmaceuticals, is actively working on ANDA formulation development for Modavar.Read More
We also closely work with leading pharmaceutical companies to support their contract manufacturing needs in the U.S. and Europe. With our FDA-compliant facility in the U.S., we are able to support contract development and manufacturing of controlled substances and hormone-based products.Read More
Details of our FDA-approved pharmaceutical products are available.Read More
Our state-of-the-art facility in India is not only impressive in size but also US FDA approved. In addition to being US FDA compliant, our facility is also approved by WHO Geneva, UK MHRA, TGA Australia, MCC South Africa, and ANVISA Brazil. Our U.S. facility is fully FDA compliant and designed to develop and manufacture controlled substances and hormones.
Finished formulations and intermediate manufacturing of active pharmaceutical ingredients (API)
Capacity and flexibility to handle large-scale production
Systems automation for optimal efficiency and product quality
International quality, regulatory and supply chain management expertise
Strong corporate stability and access to experts company wide
Full range of cGMP compliant manufacturing services for prescription products
Modavar, in collaboration with Cadila Pharmaceuticals, India, is committed to supply affordable, quality formulations using some of the most innovative research methods and cutting-edge manufacturing processes.
We will discover, develop and successfully market pharmaceutical products to prevent,diagnose, alleviate and cure diseases.
Modavar Pharmaceuticals, LLC was established in 2005. Modavar is a subsidiary of Cadila Pharmaceuticals, Ltd., India, the largest privately-owned pharmaceutical company in India.
In addition to marketing generic products under the Modavar label, Modavar has invested in its own innovative product pipeline.